Hubungan Sindrom Metabolik dengan Penyakit Ginjal Kronis: Literature Review
Abstract
The prevalence of metabolic syndrome in the world continues to increase every year. Various studies have been conducted to investigate the impacts of metabolic syndrome. Most studies prove that metabolic syndrome is associated with increased risk of progressive decrease in kidney function and developing chronic kidney disease in the future. The aim of this literature review is to analyze the relationship and pathophysiological mechanisms between metabolic syndrome and chronic kidney disease. The result of this review shows there is a significant relationship between metabolic syndrome and chronic kidney disease. The presence of metabolic syndrome increases the risk of developing chronic kidney disease in the future, quicken the decline of kidney function, and increases risk of mortality. Metabolic syndrome triggers excessive production of pro-inflammatory cytokines and activation of RAAS (renin-angiotensin-aldosterone system) that causes chronic kidney disease. To prevent the incidence of chronic kidney disease in the future, it is necessary to do prevention such as control healthy diet and lifestyle so we do not suffer metabolic syndrome. In addition, it is important to control the components of metabolic syndrome suffered along with improving diet and lifestyle to prevent severity of metabolic syndrome.
Keywords
Full Text:
PDFReferences
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., Ahmadian, E., Al-Aly, Z., Alipour, V., Almasi-Hashiani, A., Al-Raddadi, R. M., Alvis-Guzman, N., Amini, S., Andrei, T., Andrei, C. L., … Vos, T. 2020. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 395(10225), 709–733.
Chen, J., Kong, X., Jia, X., Li, W., Wang, Z., Cui, M., & Xu, D. 2017. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population. Clinica Chimica Acta, 470, 103–108.
Grundy, S. M. 2016. Metabolic syndrome update. Trends in Cardiovascular Medicine, 26(4), 364–373.
Han, T. S., & Lean, M. E. J. 2015. Metabolic syndrome. Medicine, 43(2), 80–87.
Hirode, G., & Wong, R. J. 2020. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016. Jama, 323(24), 2526–2528.
Huh, J. H., Yadav, D., Kim, J. S., Son, J.-W., Choi, E., Kim, S. H., Shin, C., Sung, K.-C., & Kim, J. Y. 2017. An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study. Metabolism, 67, 54–61.
Jazani, N. H., Savoj, J., Lustgarten, M., Lau, W. L., & Vaziri, N. D. 2019. Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases, 7(1), 1.
Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., & Kikuchi, A. 2019. Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese. International Urology and Nephrology, 51(12), 2285–2294.
Kementerian Kesehatan Republik Indonesia. 2018. Laporan Nasional RISKESDAS 2018. Badan Penelitian dan Pengembangan Kesehatan.
Lakkis, J. I., & Weir, M. R. 2018. Obesity and Kidney Disease. Progress in Cardiovascular Diseases, 61(2), 157–167.
Lee, S. J., Lee, H. J., Oh, H. J., Go, T., Kang, D. R., Kim, J. Y., & Huh, J. H. 2018. Metabolic syndrome status over 2 years predicts incident chronic kidney disease in mid-life adults: A 10-year prospective cohort study. Scientific Reports, 8(1), 12237.
Li, Y., Xie, D., Qin, X., Tang, G., Xing, H., Li, Z., Xu, X., Xu, X., & Hou, F. 2015. Metabolic syndrome, but not insulin resistance, is associated with an increased risk of renal function decline. Clinical Nutrition, 34(2), 269–275.
Lin, J.-H., Wu, H.-C., Huang, W.-H., Lu, C.-L., Cheng, M.-H., Wang, H.-T., Yen, T.-H., & Wang, W.-J. 2015. Association between management of metabolic syndrome and progression of early-stage chronic kidney disease: An observational cohort study. Renal Failure, 37(1), 29–36.
Lv, J.-C., & Zhang, L.-X. 2019. Prevalence and disease burden of chronic kidney disease. Renal Fibrosis: Mechanisms and Therapies, 3–15.
Maleki, A., Montazeri, M., Rashidi, N., Montazeri, M., & Yousefi-Abdolmaleki, E. 2015. Metabolic syndrome and its components associated with chronic kidney disease. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, 20(5), 465–469.
Mendy, V. L., Azevedo, M. J., Sarpong, D. F., Rosas, S. E., Ekundayo, O. T., Sung, J. H., Bhuiyan, A. R., Jenkins, B. C., & Addison, C. 2014. The Association between Individual and Combined Components of Metabolic Syndrome and Chronic Kidney Disease among African Americans: The Jackson Heart Study. PLOS ONE, 9(7), e101610.
Mennuni, S., Rubattu, S., Pierelli, G., Tocci, G., Fofi, C., & Volpe, M. 2014. Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage. Journal of Human Hypertension, 28(2), Article 2.
Pammer, L. M., Lamina, C., Schultheiss, U. T., Kotsis, F., Kollerits, B., Stockmann, H., Lipovsek, J., Meiselbach, H., Busch, M., Eckardt, K., Kronenberg, F., & for the GCKD Investigators. 2021. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. Journal of Internal Medicine, 290(6), 1219–1232.
Park, S., Lee, S., Kim, Y., Lee, Y., Kang, M. W., Han, K., Lee, H., Lee, J. P., Joo, K. W., Lim, C. S., Kim, Y. S., & Kim, D. K. 2020. Reduced risk for chronic kidney disease after recovery from metabolic syndrome: A nationwide population-based study. Kidney Research and Clinical Practice, 39(2), 180–191.
Qiu, Y., Zhao, Q., Gu, Y., Wang, N., Yu, Y., Wang, R., Zhang, Y., Zhu, M., Liu, X., Jiang, Y., & Zhao, G. 2019. Association of Metabolic Syndrome and Its Components with Decreased Estimated Glomerular Filtration Rate in Adults. Annals of Nutrition and Metabolism, 75(3), 168–178.
Raikou, V. D., & Gavriil, S. 2018. Metabolic Syndrome and Chronic Renal Disease. Diseases, 6(1), Article 1.
Singh, A. K., & Kari, J. A. 2013. Metabolic syndrome and chronic kidney disease: Current Opinion in Nephrology and Hypertension, 22(2), 198–203.
Su, G., Qin, X., Yang, C., Sabatino, A., Kelly, J. T., Avesani, C. M., Carrero, J. J., & on behalf of the ERA European Renal Nutrition Working Group, an official body of the E. 2022. Fiber intake and health in people with chronic kidney disease. Clinical Kidney Journal, 15(2), 213–225.
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. 2017. Chronic Kidney Disease. The Lancet, 389(10075), 1238–1252.
Wu, M., Shu, Y., Wang, L., Song, L., Chen, S., Liu, Y., Bi, J., Li, D., Yang, Y., Hu, Y., Wang, Y., Wu, S., & Tian, Y. 2022. Metabolic syndrome severity score and the progression of CKD. European Journal of Clinical Investigation, 52(1), e13646.
Yu, A. S. L., 2020. Brenner & Rector’s the kidney, Eleventh edition. Elsevier.
Zhang, X., & Lerman, L. O. 2017. The metabolic syndrome and chronic kidney disease. Translational Research, 183, 14–25.
Zomorrodian, D., Khajavi-Rad, A., Avan, A., Ebrahimi, M., Nematy, M., Azarpazhooh, M. R., Emamian, M., Sadeghzade, M., Mirhafez, S. R., Mohammadi, M., Mousavi, M., Esmaeili, H., Moohebati, M., Parizadeh, M. R., Ferns, G. A., & Ghayour-Mobarhan, M. 2015. Metabolic syndrome components as markers to prognosticate the risk of developing chronic kidney disease: Evidence-based study with 6492 individuals. Journal of Epidemiology and Community Health, 69(6), 594–598.
DOI: http://dx.doi.org/10.33087/jiubj.v23i3.4171
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
|
